(Q73869659)

English

[Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers. Groupe d'étude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD)]

scientific article published on 01 January 1997

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

[Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers. Groupe d'étude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD)] (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

A de Gramont

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C Louvet

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C Tournigand

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

E Raymond

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J L Molitor

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Krulik

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 January 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Revue de Médecine Interne

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

18 Suppl 4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

372s-378s

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil: biochemistry and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary evidence that incorporation of 5-fluorouracil into RNA correlates with antitumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

[Evolution from pharmacokinetics to pharmacogenetics. The example of 5-fluorouracil]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2897%2983768-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0248-8663(97)83768-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9365715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73869659&oldid=1753488035"